A detailed history of Jane Street Group, LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 164,281 shares of PSNL stock, worth $944,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
164,281
Previous 64,610 154.27%
Holding current value
$944,615
Previous $75,000 1077.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.19 - $6.34 $118,608 - $631,914
99,671 Added 154.27%
164,281 $883,000
Q2 2024

Aug 14, 2024

BUY
$1.17 - $1.65 $1,239 - $1,747
1,059 Added 1.67%
64,610 $75,000
Q1 2024

May 15, 2024

BUY
$1.15 - $2.19 $50,727 - $96,603
44,111 Added 226.91%
63,551 $94,000
Q4 2023

Feb 14, 2024

BUY
$0.93 - $2.35 $18,079 - $45,684
19,440 New
19,440 $40,000
Q1 2023

May 15, 2023

BUY
$2.01 - $4.17 $131,538 - $272,893
65,442 Added 261.22%
90,494 $249,000
Q4 2022

Feb 14, 2023

SELL
$1.78 - $3.64 $11,413 - $23,339
-6,412 Reduced 20.38%
25,052 $49,000
Q3 2022

Nov 14, 2022

SELL
$2.89 - $5.32 $106,299 - $195,680
-36,782 Reduced 53.9%
31,464 $93,000
Q2 2022

Aug 16, 2022

BUY
$3.27 - $8.76 $223,164 - $597,834
68,246 New
68,246 $235,000
Q1 2022

May 17, 2022

SELL
$7.56 - $14.3 $183,745 - $347,561
-24,305 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$12.24 - $21.25 $83,513 - $144,988
-6,823 Reduced 21.92%
24,305 $347,000
Q1 2021

May 18, 2021

SELL
$20.71 - $51.02 $531,667 - $1.31 Million
-25,672 Reduced 45.2%
31,128 $766,000
Q4 2020

Feb 17, 2021

BUY
$21.84 - $44.0 $1.24 Million - $2.5 Million
56,800 New
56,800 $2.08 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $264M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.